scholarly article | Q13442814 |
P2093 | author name string | Li Zhang | |
Hua Wang | |||
Yin Chen | |||
Tao Wu | |||
Xiao Zhang | |||
Xian Qi | |||
Changjun Bao | |||
Minghao Zhou | |||
Ying Chi | |||
Xian Li | |||
Jianli Hu | |||
Qiu Jin | |||
Xiaoyan Zeng | |||
Lin Bao | |||
Mingming Huang | |||
Xiling Guo | |||
Yongjun Jiao | |||
Shuyi Liang | |||
Wenshuai Zhang | |||
P2860 | cites work | Fever with thrombocytopenia associated with a novel bunyavirus in China | Q24615216 |
Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses | Q24649949 | ||
Antibody recognition of a highly conserved influenza virus epitope | Q24655932 | ||
Isolation and Characterization of Human Monoclonal Antibodies from Individuals Infected with West Nile Virus | Q27473288 | ||
Human monoclonal antibody combination against SARS coronavirus: synergy and coverage of escape mutants | Q28768526 | ||
One step closer to universal influenza epitopes | Q30227646 | ||
The genesis of a pandemic influenza virus. | Q30351764 | ||
A neutralizing recombinant human antibody Fab fragment against Puumala hantavirus | Q30841213 | ||
Generation of an HFRS patient-derived neutralizing recombinant antibody to Hantaan virus G1 protein and definition of the neutralizing domain | Q30870545 | ||
Human recombinant neutralizing antibodies against hantaan virus G2 protein | Q31139620 | ||
Construction of human naïve Fab library and characterization of anti-met Fab fragment generated from the library | Q33222167 | ||
Person-to-person transmission of severe fever with thrombocytopenia syndrome virus | Q33397384 | ||
A family cluster of infections by a newly recognized bunyavirus in eastern China, 2007: further evidence of person-to-person transmission | Q33397816 | ||
Person-to-person transmission of severe fever with thrombocytopenia syndrome bunyavirus through blood contact | Q33398319 | ||
Sporadic case infected by severe fever with thrombocytopenia syndrome bunyavirus in a non-epidemic region of China | Q33399366 | ||
Acute Thrombocytopenia, Leucopenia, and Multiorgan Dysfunction: The First Case of SFTS Bunyavirus outside China? | Q33401110 | ||
Severe fever with thrombocytopenia syndrome virus, Shandong Province, China | Q33401291 | ||
Critical epitopes in the nucleocapsid protein of SFTS virus recognized by a panel of SFTS patients derived human monoclonal antibodies | Q33401906 | ||
A new phlebovirus associated with severe febrile illness in Missouri. | Q33403011 | ||
Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. The Respiratory Syncytial Virus Immune Globulin Study Group | Q34358628 | ||
An antibody recognizing the apical domain of human transferrin receptor 1 efficiently inhibits the entry of all new world hemorrhagic Fever arenaviruses. | Q35826829 | ||
Passive antibody therapy for infectious diseases | Q35889582 | ||
Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association | Q36602721 | ||
The growth and potential of human antiviral monoclonal antibody therapeutics. | Q37027166 | ||
Phase I evaluation of the safety and pharmacokinetics of a single-dose intravenous injection of a murine monoclonal antibody against Hantaan virus in healthy volunteers | Q37450799 | ||
Expression and purification of a recombinant scFv towards the exotoxin of the pathogen, Burkholderia pseudomallei | Q40484255 | ||
Expression of a human, neutralizing monoclonal antibody specific to puumala virus G2-protein in stably-transformed insect cells | Q40836694 | ||
A novel bunyavirus in China. | Q44005619 | ||
Intravenous immune globulin for prevention of cytomegalovirus infection and interstitial pneumonia after bone marrow transplantation | Q44717088 | ||
Evaluation of the safety and immunogenicity of a new, heat-treated human rabies immune globulin using a sham, post-exposure prophylaxis of rabies | Q47935486 | ||
An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus | Q47957009 | ||
P433 | issue | 9 | |
P921 | main subject | thrombocytopenia | Q585285 |
severe fever with thrombocytopenia syndrome | Q3508725 | ||
SFTS virus | Q5313087 | ||
P304 | page(s) | 1426-1432 | |
P577 | publication date | 2013-07-17 | |
P1433 | published in | Clinical and Vaccine Immunology | Q5133811 |
P1476 | title | Human antibody neutralizes severe Fever with thrombocytopenia syndrome virus, an emerging hemorrhagic Fever virus | |
P478 | volume | 20 |
Q33433046 | A serological study of severe fever with thrombocytopenia syndrome using a virus neutralization test and competitive enzyme-linked immunosorbent assay |
Q63246516 | An anti-Gn glycoprotein antibody from a convalescent patient potently inhibits the infection of severe fever with thrombocytopenia syndrome virus |
Q56555380 | An emerging novel goose astrovirus associated with gosling gout disease, China |
Q104495189 | Baseline mapping of severe fever with thrombocytopenia syndrome virology, epidemiology and vaccine research and development |
Q33418466 | Characterization of severe fever with thrombocytopenia syndrome in rural regions of Zhejiang, China. |
Q33427270 | Combination effects of ribavirin and interferons on severe fever with thrombocytopenia syndrome virus infection |
Q30235493 | Current status of severe fever with thrombocytopenia syndrome in China |
Q33427065 | Development and Characterization of Monoclonal Antibodies Directed Against the Nucleoprotein of Heartland Virus |
Q93208489 | Development and evaluation of a rapid detection assay for severe fever with thrombocytopenia syndrome virus based on reverse-transcription recombinase polymerase amplification |
Q57212939 | Heartland Virus Epidemiology, Vector Association, and Disease Potential |
Q33439713 | Hemorrhagic fever of bunyavirus etiology: disease models and progress towards new therapies |
Q33436197 | Neutralizing Antibodies to Severe Fever with Thrombocytopenia Syndrome Virus 4 Years after Hospitalization, China |
Q92058575 | Nucleocapsid protein-specific IgM antibody responses in the disease progression of severe fever with thrombocytopenia syndrome |
Q92350550 | Persistence and gender differences in protection against severe fever with thrombocytopaenia syndrome virus with natural infection: a 4-year follow-up and mathematical prediction study |
Q33415380 | Severe fever with thrombocytopenia syndrome, an emerging tick-borne zoonosis |
Q61443781 | Single dose of a rVSV-based vaccine elicits complete protection against severe fever with thrombocytopenia syndrome virus |
Q38615473 | Structures of phlebovirus glycoprotein Gn and identification of a neutralizing antibody epitope |
Q34059387 | Uukuniemi Phlebovirus assembly and secretion leave a functional imprint on the virion glycome |
Q33436980 | Vertebrate Host Susceptibility to Heartland Virus |